Eli Lilly and Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Eli Lilly and Company generated cash of $4,240,100,000, which is less than the previous year. Cash used in financing activities reached the amount of $3,495,600,000 last year. Net change in cash is therefore $751,600,000.
Cash Flow
| 2014 | 4.36B | -3.90B | -75.1M |
|---|---|---|---|
| 2015 | 2.77B | 26.8M | -2.91B |
| 2016 | 4.85B | -3.13B | -559.8M |
| 2017 | 5.61B | -3.78B | 142.6M |
| 2018 | 5.52B | 1.90B | -5.90B |
| 2019 | 4.83B | -8.08B | -2.32B |
| 2020 | 6.49B | -2.25B | -3.13B |
| 2021 | 7.26B | -2.76B | -4.13B |
| 2022 | 7.08B | -3.26B | -5.40B |
| 2023 | 4.24B | -7.15B | 3.49B |
LLY.SW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.06B | 3.81B | 3.65B | 2.33B | 7.99B | 6.53B | 4.58B | 3.66B | 3.87B | 3.83B |
Operating activities | ||||||||||
Net income | 5.24B | 6.24B | 5.58B | 6.19B | 8.31B | 3.23B | -204.1M | 2.73B | 2.40B | 2.39B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.52B | 1.52B | 1.54B | 1.32B | 1.23B | 1.60B | 1.56B | 1.49B | 1.42B | 1.37B |
Stock-based compensation expense | 628.5M | 371.1M | 342.8M | 308.1M | 312.4M | 279.5M | 281.3M | 255.3M | 217.8M | 156M |
| Deferred income tax benefit | 628.5M | 371.1M | 342.8M | 308.1M | 312.4M | 279.5M | 281.3M | 255.3M | 217.8M | 156M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.45B | -299.6M | -1.27B | -1.35B | -127.2M | -996.7M | -357M | -709.4M | -304.5M | 117.4M |
Inventories | -1.42B | -599.7M | -235.9M | -533.4M | -258.7M | 7.8M | -253.9M | -328.2M | -736.3M | -307.1M |
Accounts payable | 4.27B | 1.33B | -664.1M | 1.27B | -477.7M | -284.5M | 916.3M | 819M | 461.6M | -260.7M |
Cash generated by operating activities | 4.24B | 7.08B | 7.26B | 6.49B | 4.83B | 5.52B | 5.61B | 4.85B | 2.77B | 4.36B |
Investing activities | ||||||||||
Purchases Of Investments | -829M | -707.6M | -1.01B | -370.1M | -290.2M | -950.1M | -8.00B | -5.67B | -4.06B | -11.44B |
Investments In Property Plant And Equipment | -3.44B | -2.48B | -1.87B | -2.02B | -1.35B | -3.01B | -2.16B | -1.09B | -1.62B | -1.56B |
Acquisitions Net | -1.04B | -327.2M | -747.4M | -849.3M | -6.93B | 1.80B | -882.1M | -45M | -5.28B | -551.4M |
Cash generated by investing activities | -7.15B | -3.26B | -2.76B | -2.25B | -8.08B | 1.90B | -3.78B | -3.13B | 26.8M | -3.90B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 2.40B | 568.1M | 0 | 1.65B | 0 | 2.49B | 0 | 3.67B |
Payments for dividends | -4.06B | -3.53B | -3.08B | -2.68B | -2.40B | -2.31B | -2.19B | -2.15B | -2.12B | -2.10B |
Repurchases of common stock | -750M | -1.5B | -1.25B | -500M | -4.4B | -4.15B | -299.8M | -600.1M | -749.5M | -800M |
Repayments of term debt | 3.95B | -1.56B | -1.90B | -276.5M | 4.68B | -1.00B | 1.60B | -200K | -181.6M | -1.03B |
Cash used in financing activities | 3.49B | -5.40B | -4.13B | -3.13B | -2.32B | -5.90B | 142.6M | -559.8M | -2.91B | -75.1M |
Net Change In Cash | 751.6M | -1.75B | 161.4M | 1.31B | -5.66B | 1.46B | 1.95B | 915.7M | -205.2M | 41.4M |
Cash at end of period | 2.81B | 2.06B | 3.81B | 3.65B | 2.33B | 7.99B | 6.53B | 4.58B | 3.66B | 3.87B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |